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ReviewThe Role of PML
in Tumor Suppression
RAR fusion protein and underscoring the importance
in leukemogenesis of the functional disruption of PML
and the PML-NB (Pandolfi, 2001, and references
Paolo Salomoni and Pier Paolo Pandolfi1
Molecular Biology Program and Department of
Pathology
Sloan-Kettering Institute therein). Coexpression of RAR-PML with PML-RAR
results in an increase of leukemia incidence (Pollock etMemorial Sloan-Kettering Cancer Center
New York, New York 10021 al., 1999). To date, work has focused on PML and PML-
RAR, while the function of RAR-PML is still unknown.
It is now becoming apparent that PML is essential for
critical tumor suppressive pathways that are deregu-The PML gene, involved in the t(15;17) chromosomal
translocation of acute promyelocytic leukemia (APL), lated in APL.
encodes a protein which localizes to the PML-nuclear
body, a subnuclear macromolecular structure. PML PML and PML-NB Biogenesis
controls apoptosis, cell proliferation, and senescence. Few hints have come from PML’s primary structure.
Here, we review the current understanding of its role PML is one of the founding members of a growing family
in tumor suppression. of proteins harboring a distinctive C3HC4 zinc finger do-
main termed the RING (really interesting gene) domain.
Understanding PML function has become an area of Other members of the RING family of proteins have also
intense research because of its involvement in the been implicated in tumor suppression and in genomic
pathogenesis of acute promyelocytic leukemia (APL), a instability (e.g., BRCA1; Jensen et al., 2001; Zhong et
distinct subtype of myeloid leukemia. In the vast majority al., 2000b, and references cited therein). The PML RING
of APL patients, the PML gene (on chromosome 15) finger is located N terminally and is followed by two
fuses to the retinoic acid (RA) receptor  (RAR) gene additional zinc fingers (B boxes) and an -helical coiled-
(on chromosome 17) as a consequence of reciprocal coil motif (collectively referred to as the RBCC domain).
and balanced chromosomal translocations. The re- The RBCC domain mediates protein-protein interac-
sulting two fusion genes generated encode PML-RAR tions and is responsible for PML multimerization, local-
and RAR-PML fusion proteins, which are both ex- ization in the PML-NB, and heterodimerization with
pressed in the leukemic cells (Melnick and Licht, 1999, PML-RAR, but doesn’t confer DNA binding capability
and references cited therein). RAR belongs to the nu- (Zhong et al., 2000b; Jensen et al., 2001). Multiple PML
clear hormone receptor superfamily of transcription isoforms have been identified due to alternative splicing.
factors. Upon ligand (RA) binding, RAR transactivates While most PML isoforms are associated with the PML-
target genes critical for the induction of myeloid hemo- NB and the nuclear matrix, some of these isoforms are
poietic cells’ terminal differentiation. PML-RAR retains found to accumulate into the cytosolic fraction (Jensen
both DNA and ligand binding domains of RAR and et al., 2001, and references therein).
can inhibit its transcriptional function through aberrant To date, more than 30 proteins are found to colocalize
recruitment of corepressors and histone deacetylases, with PML in the NB either transiently or constitutively
thus acting as a dominant-negative RAR mutant (Mel- (Jensen et al., 2001). A small number of these proteins
nick and Licht, 1999). With the availability of an antibody have been shown to physically interact with PML, includ-
against PML, it has now been demonstrated that PML- ing p53, pRb, DAXX, CBP, and eIF4E. The relevance of
RAR also affects PML function. PML was shown to be these interactions will be described further in this review.
concentrated in novel speckled subnuclear structures Surprisingly, however, in PML/ primary cells, each
which have been variably named PML nuclear bodies PML-NB component so far analyzed acquires an aber-
(PML-NBs), Kremer bodies, ND10 (nuclear domain 10) rant nuclear localization pattern and PML add-back is
or POD (for PML oncogenic domains) (Jensen et al., able to rescue normal localization (Zhong et al. 2000a;
2001, and references cited therein). Electron microscopy Lallemand-Breitenbach et al., 2001). Modification of
analysis reveals that the PML-NB is a macromolecular PML by the ubiquitin-like protein SUMO1 is essential
structure of doughnut shape (approximately 0.2–1.0 mi- for proper formation of the PML-NB (Zhong et al. 2000a).
crometer in size). Cells typically contain 10–30 of these This was demonstrated with a mutant of PML that can-
macromolecular structures, although their number and not be SUMOylated and is unable to restore proper PML-
size change during the cell cycle (Zhong et al., 2000b). NB formation in PML/ cells. The recent identification
In the APL blasts, PML-RAR caused the delocalization of enzymes that can remove the SUMO1 moiety from
of PML into microspeckled nuclear structures through its substrate such as ULP1 and SENP1, indicate that
physical association, and the consequent disruption of PML SUMOylation is dynamic and possibly subject to
the PML-NB (Melnick and Licht, 1999). In transgenic tight regulation (Zhong et al., 2000b, and references
mice, when expressed in the promyelocytic/myeloid therein). All together, these findings uncover an unex-
compartment, PML-RAR causes leukemia with APL pected role for PML in the formation and stability of the
features while dominant-negative RAR mutants fail to PML-NB, in turn implying that PML may regulate the
do so, revealing the oncogenic potential of the PML- PML-NB-dependent functions of multiple PML-NB pro-
teins. These observations also provide a direct explana-
tion for the reason why PML-RAR causes the delocal-1Correspondence: p-pandolfi@ski.mskcc.org
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ization of PML and of all PML-NB components, even if
many of these proteins do not physically interact with the
fusion protein. The essential role of PML in the control of
PML-NB biogenesis was unforeseen and suggested that
PML may modulate diverse and even opposing func-
tions. Recent reports indicate that PML harmonically
coordinates, at least in part from the PML-NB, critical
tumor suppressive functions such as induction of apo-
ptosis, growth arrest, and cellular senescence.
PML and Control of Apoptosis
PML is essential for multiple stress/DNA damage-acti-
vated apoptotic pathways. This proapoptotic activity
can be antagonized by PML-RAR, lending the leukemic
blasts a marked survival advantage. Definitive proof of
PML’s importance in the induction of apoptosis comes
from studies conducted in PML/ mice and cells.
PML/ mice are resistant to the lethal effects of both 
irradiation and CD95 (Wang et al., 1998b). Primary
PML/ cells are resistant to apoptosis induced by either
CD95 or  irradiation, as well as by ceramide, TNF, and
IFN (Wang et al., 1998b). Caspase activation is impaired
Figure 1. The PML-NB Modulates p53-Dependent Pathways for Tu-
in PML/ cells upon these stimuli. Myeloid hemopoietic mor Suppression
progenitors from PML-RAR transgenic mice are also Oncogenic transformation and DNA damage elicit cellular senes-
resistant to these apoptotic stimuli, in keeping with the cence or induction of apoptosis. These processes are regulated by
dominant-negative role exerted by PML-RAR on PML the tumor suppressor p53. PML controls the targeting of p53 into
the PML-NB, its acetylation and transcriptional activation. As a con-function (Wang et al., 1998b). Moreover, the protection
sequence, p53 target genes relevant for either apoptosis or senes-from apoptosis conferred by PML-RAR is augmented
cence are transcribed.by the reduction of PML to hemizygosity obtained by
crossing PML-RAR transgenic mice with PML/ mice
(see also below; Rego et al., 2001). This represents the PML in p53-Dependent Apoptosis
The observation that PML/ mice are resistant to thefirst in vivo genetic evidence that PML-RAR can nega-
tively affect PML function and suggests that the inactiva- lethal effects of radiation indicates that PML is involved
in the DNA-damage response. The tumor suppressortion of PML proapoptotic activity by the fusion protein
could be a crucial step in APL leukemogenesis. p53 plays a key role in this process. p53/ thymocytes
are completely resistant to  radiation-induced apopto-However, PML overexpression leads to rapid cell
death in the absence of the typical features of apoptosis, sis, indicating that p53 is absolutely required for DNA
damage-induced apoptosis in this cell type. PML/ thy-such as nuclear condensation. Furthermore, PML-
induced apoptosis (in this overexpression system) is mocytes are resistant to  radiation-induced apoptosis,
though to a lesser extent than p53/ thymocytes (Guoenhanced, rather than blocked, by a broad-spectrum
caspase inhibitor (z-VAD-fmk). Caspase-3 activity is not et al., 2000). Moreover, in PML/ thymocytes, protection
from apoptosis correlates with impaired induction ofinduced upon overexpression of PML, implying that
PML may trigger apoptosis in a caspase-independent bona fide p53 target genes such as the proapoptotic
bax and the inhibitor of cell cycle p21 (Guo et al., 2000).fashion (Quignon et al., 1998). Caspase-independent
apoptosis is not unprecedented and has been shown PML directly interacts with the DNA binding domain of
p53, colocalizes with p53 in the PML-NB, and acts asto be triggered by serum deprivation, staurosporine,
overexpression of oncogenes such as c-MYC or E1A, a p53 transcriptional coactivator. Upon  irradiation, p53
is activated by several mechanisms, one of which isDNA damage, and IL-3 withdrawal (Rathmell and
Thompson, 1999). A comprehensive assessment of acti- acetylation (Gu and Roeder, 1997). Acetylation of p53
enhances its ability to bind DNA and activate transcrip-vation of caspases other than caspase-3 is needed be-
fore a role for caspase involvement in PML-induced tion. In PML/ cells the  radiation-induced acetylation
of p53 is substantially impaired, indicating that PMLapoptosis can be excluded. The apparent contradiction
between the data obtained in vitro in overexpression might regulate p53 transcriptional function, favoring its
acetylation (Guo et al., 2000). Although PML does notstudies and in vivo in PML/ mice and cells can be
reconciled by hypothesizing that, at lower levels, PML possess intrinsic acetyltransferase activity, it directly
interacts with the acetyltransferase CBP and colocalizesis essential for the proper function of proapoptotic tran-
scription factors (see below), ultimately leading to cas- with CBP/p300 and p53 in the PML-NB (Guo et al., 2000;
Pearson et al., 2000, and references therein) (Figure 1).pase activation, while at higher levels PML might trigger
apoptosis independently of transcription or caspase ac- Strikingly, the ability of PML to activate p53 transcription
is PML-NB dependent, since a mutant of PML that can-tivation through protein sequestration into the PML-NB.
However, it can be argued that the levels of PML expres- not localize in the PML-NB, but still interacts with p53
and CBP, is unable to coactivate p53 transcription (Guosion obtained in transient transfection experiments are
not physiologically relevant. et al., 2000). Furthermore, only a specific PML isoform
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found in the PML-NB can modulate p53 transcription MEFs display an intermediate proliferation rate, sug-
gesting that PML may be haploinsufficient for growth(Fogal et al., 2000; Guo et al., 2000). Thus, at least in
suppression (see also below). The S phase populationpart through the PML-NB, PML modulates p53 function,
of PML/ MEFs is increased with a concomitant de-in turn potentiating its tumor-suppressive activity.
crease in the G0/G1 population, a change analogous toWhether the transcriptional role of PML on p53 totally
that observed in Rb/ MEFs. An increased proliferativedepends on acetylation or if PML can also affect other
rate is also observed in primary PML/ splenocytes,p53 posttranslational modifications such as SUMOyla-
thymocytes, and keratinocytes (Wang et al., 1998a,tion or phosphorylation needs to be addressed. In this
1998b). These findings conclusively demonstrate thatrespect, two very recent reports demonstrate that the
PML can function in vivo as a negative growth regulator.homeodomain-interacting protein kinase-2 (HIPK2),
More recent reports implicate PML in the induction ofwhich also colocalizes with PML into the PML-NB, di-
growth arrest and cellular senescence upon oncogenicrectly interacts with and phosphorylates p53 at serine
transformation. Oncogenic RAS (RASval12) triggers cellu-46, resulting in p53 transcriptional activation and apo-
lar senescence by inducing the expression of severalptosis (Orazi et al., 2002; Hofmann et al., 2002). Thus,
tumor suppressors, including p53 and the CDK inhibitorphosphorylation and acetylation of p53 can occur in
p16INK4a. PML is also markedly upregulated by oncogenicthe PML-NB. It remains to be addressed whether as
RAS. The resulting increase in PML protein levels leadsa consequence of the disruption of the PML-NB, p53
to a concomitant increase in the number and size ofphosphorylation at serine 46 by HIPK2 is impaired.
PML-NBs (Ferbeyre et al., 2000; Pearson et al., 2000).DAXX: PML’s Partner in Crime
Conversely, PML overexpression leads to p53 inductionThe fact that PML is necessary for FAS and TNF-
(Ferbeyre et al., 2000). Furthermore, RASval12 triggers theinduced apoptosis indicates that PML also modulates
accumulation of p53 in the PML-NB and induce its acet-p53-independent proapoptotic pathways, such as the
ylation and transcriptional activation (Pearson et al.,one triggered by the death inducing signaling complex
2000). PML, p53, and CBP form a RAS-inducible com-(DISC) at the plasma membrane. The search is ongoing
plex in vivo, and colocalize in the PML-NB (Pearson etfor molecules that can transduce the FAS/TNF signal
al., 2000). However, conclusive evidence that PML, likefrom the plasma membrane to the PML-NB. To date,
p53, is essential for the induction of cellular senescencethe most relevant candidate to serve this function is
upon oncogenic transformation comes from the obser-DAXX, originally cloned as a FAS-interacting protein and
vation that in PML1 cells, RasVa112-induced senescencefound to act as a positive mediator of FAS- and
is drastically impaired (Pearson et al., 2000). RASval12-TGF-induced apoptosis (Perlman et al., 2001 and refer-
induced p53 acetylation is profoundly impaired inences cited therein). DAXX directly interacts with both
PML/ cells. However, RAS-dependent induction of p53PML and PML-RAR (Li et al., 2000; Zhong et al., 2000c).
is not substantially diminished in PML/ MEFs, indicat-In the absence of PML, DAXX is delocalized from the
ing that PML is required for p53 transcriptional activity,PML-NB and accumulates in chromatin-dense nuclear
but not its stability or expression. Taken together, theseregions (Zhong et al., 2000c). Furthermore, in PML/
findings support a model by which RASval12 induces PMLcells, the ability of DAXX to trigger apoptosis and to
expression, which in turn facilitates p53 acetylation andpotentiate the FAS proapoptotic signal is markedly im-
transcriptional activation, resulting in the upregulation ofpaired. DAXX represses basal transcription and its se-
p21 and subsequent growth arrest (Figure 1). In keepingquestration in the PML-NB blocks this activity. Con-
with these findings, the ability of RAS to induce the p53versely, expression of PML-RAR results in the
target gene p21 is also impaired in PML/ cells (Pearsondelocalization of DAXX from the PML-NB, in turn en-
et al., 2000). Whether acetylation releases p53 from thehancing DAXX transcriptional repression (Li et al., 2000).
PML-NB or whether transcription of p53 target genes oc-PML can therefore modulate at the transcription level
curs in the vicinity of the NB remains to be established.
both p53-dependent and -independent pathways for
PML physically interacts with the tumor suppressor
apoptosis through the NB.
retinoblastoma protein (pRb), which is also found in the
PML-NB and is implicated in the control of cell cycle
Cellular Proliferation and Senescence entry and cellular senescence (Alcalay et al., 1998). Nu-
The expression of PML and other PML-NB components merous proteins have been found to interact with the
is markedly induced by type I and II interferon. As a highly abundant pRb protein and the relevance of these
consequence, the number and size of PML-NBs per interactions has only been proved for a few of them,
nucleus increases (Zhong et al., 2000b; Jensen et al., prompting a functional assessment of the PML/pRb in-
2001). This suggested that PML and the PML-NB could teraction. In this regard, it has been recently reported
mediate IFN-regulated cellular functions, including that PML can associate with a macromolecular complex,
growth and tumor-suppressive activity. Indeed, in over- containing corepressors such as N-CoR/SMRT, mSin3,
expression studies, in tumor cell lines from various histo- Ski/Sno, and histone deacetylases (HDAC1), in the PML-
logical origins, PML acts as a potent growth suppressor NB. This complex is essential for the transcriptional re-
by inducing a block in the G1 phase of cell cycle (Le et pression mediated by the tumor suppressors MAD and
al., 1998, and references cited therein). Although these pRb (Khan et al., 2001a, and references cited therein).
data suffer from the obvious limitations of overexpres- Furthermore, PML was found to potentiate pRb tran-
sion studies carried out in cell lines, concordant informa- scriptional repression while PML-RAR can antagonize
tion comes from the analysis of primary PML/ cells. this function (Khan et al., 2001b). In PML/ MEFs, the
Mouse embryonic fibroblasts (MEFs) grow much faster ability of both pRb and Mad to repress transcription is
markedly impaired (Khan et al., 2001a, 2001b).than the wild-type counterpart. Interestingly, PML/
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tumor promoter 12-0-tetra-decanoylphorbol-13-acetate
[TPA]; systemic injection of DMBA into the salivary
glands, which normally induces sarcomas and fibrosar-
comas in wild-type animals, in PML/ mice induces
more tumors with a radically different spectrum: T and
B cell lymphomas of clonal origin and malignant fibrohis-
tiocytomas; increased leukemogenesis after systemic
exposure to sublethal doses of ionizing radiation [ rays]
[Wang et al., 1998a, 1998b]). Together, these data indi-
cate that PML can act in vivo as a tumor suppressor;
however, evidence that PML opposes tumorigenesis in a
relevant disease context was still lacking. As previously
discussed, PML-RAR can cause the disruption of the
PML-NB and the relocalization of PML and PML-NB
components to aberrant nuclear sites. The inactivation
of the PML’s tumor suppressive function by the fusion
protein may therefore represent a crucial step in leuke-
mogenesis. Moreover, in APL, PML is reduced to hemi-
zygosity as a consequence of the t(15;17). This may in
turn facilitate the dominant-negative action of the fusion
protein. Definitive support to this hypothesis was ob-Figure 2. The PML-NB Regulates the Assembly and Function of
Transcription Factor Complexes Required for Tumor Suppression tained in vivo by crossing PML-RAR transgenic mice
PML controls the NB-dependent acetylation of p53 by p300/CBP with PML/ animals. PML inactivation resulted in a dra-
and its transcriptional activation for apoptosis or cellular senes- matic increase of leukemia incidence and an accelera-
cence (left box). The transcription corepressor DAXX is targeted into tion of its onset. Leukemogenesis was also markedly
the PML-NB, from where it modulates DISC-dependent apoptosis enhanced in a PML/ background, demonstrating that
(middle box). PML-NB accumulation of an HDAC/N-CoR/Ski-
PML is haploinsufficient in antagonizing the leukemo-repressing complex is required for MAD and Rb transcription (right
genic function of PML-RAR (Rego et al., 2001).box).
These findings clearly indicate that PML can act as
a tumor suppressor in vivo and that PML functional
inactivation may be critical in APL leukemogenesis. AtThus, PML enhances the transcriptional function of
the cellular level, PML controls functions such as induc-critical growth and tumor suppressors (Figure 2). These
tion of apoptosis, growth suppression and cellular se-functions can be deregulated as a consequence of the
nescence upon oncogenic transformation. These func-dominant-negative action of PML-RAR on PML in the
tions are in part dependant on the PML-NB and are keyAPL blasts or in tumors lacking PML.
to the tumor suppressive role of PML (Figure 2).
The Tumor Suppressive Role of PML
In overexpression studies, PML suppresses anchorage- Outstanding Questions
PML in Human Tumorigenesisindependent growth of cells transformed by ERBB2 or
Ha-RAS in combination with oncogenic mutants of p53 The ability of PML to modulate key tumor suppressive
pathways whose inactivation has been directly involvedor c-MYC. This doesn’t rule out the possibility that PML
would simply exert cytostatic and growth suppressive in human tumorigenesis suggests that its functional and
physical inactivation may participate in the pathogene-activities when overexpressed, rather than acting as a
tumor suppressor. In these assays, PML-RAR always sis of malignancies other than APL. In this respect, PML
and the PML-NB have been recently implicated in theacts as a dominant-negative PML mutant (Le et al., 1998,
and references cited therein). Moreover, while PML/ suppression of the Wnt/-catenin signaling pathway.
Alterations in the regulation of this pathway have beenMEFs form a greater number of colonies, achieve higher
cellular densities compared to PML/ MEFs, and form shown to be involved in oncogenic transformation.
PIASy, a nuclear matrix-associated SUMO E3 ligase, hasfoci, they are unable to grow in a semisolid medium,
unlike fully transformed cells (Wang et al., 1998a). Thus, been found to repress the activity of the Wnt-responsive
transcription factor LEF1 by sequestration into the PML-the most compelling evidence of PML’s tumor suppres-
sor function comes from the analysis of tumorigenesis NB (Sachdev et al., 2001). Whether PML is lost or mu-
tated in tumors triggered by the activation of this path-and leukemogenesis in PML/ mutants. PML/ mice
thrive and do not develop tumors spontaneously in a way, such as in colon cancer, remains to be established.
A comprehensive search for PML mutations and theone-year follow-up (most of the homozygous mutants
succumb to infections after one year of age, thus com- analysis of the status and subnuclear localization of
the PML protein in tumors is needed to answer thispromising a long-term assessment of tumor incidence
[Wang et al., 1998a]). However, PML/ mice are highly important question.
A Role in Genomic Stability?susceptible to develop tumors in several in vivo models
of physical- or chemical-induced carcinogenesis (e.g., Leukemia in PML-RAR transgenic mice develops after
a long latency (more than one year and only in approxi-increased skin papillomagenesis and carcinomagenesis
upon single application of the tumor initiator dimethyl- mately 20% of the mice), which suggests that additional
genetic events have to occur and cooperate with thebenzanthracene [DMBA] followed by treatment with the
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